Thermal response in acute porcine malignant hyperthermia

Anesthesia and Analgesia

Volumn 82, Issue 4, 1996, Pages 782-789

  Iaizzo, Paul A ^a,c   Kehler, Chris H ^a   Zink, Robert S ^a   Belani, Kumar G ^a   Sessler, Daniel I ^b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Box 294 UMHC ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; HALOTHANE; INHALATION ANESTHETIC AGENT; MUSCLE RELAXANT AGENT; NITROUS OXIDE; SUXAMETHONIUM; THIOPENTAL;

ANESTHESIA COMPLICATION; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEMODYNAMIC MONITORING; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALIGNANT HYPERTHERMIA; NONHUMAN; ORGAN BLOOD FLOW; PRIORITY JOURNAL; SKELETAL MUSCLE; SKIN BLOOD FLOW; SKIN TEMPERATURE; SWINE; TEMPERATURE MEASUREMENT;

ACUTE DISEASE; ANIMALS; BODY TEMPERATURE REGULATION; HALOTHANE; MALIGNANT HYPERTHERMIA; MUSCLES; SKIN; SUCCINYLCHOLINE; SWINE; TIME FACTORS;

EID: 0029998804     PISSN: 00032999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000539-199604000-00019     Document Type: Article

References (35)

1. Gronert GA. Malignant hyperthermia. In: Engel AG, Franzini-Armstrong C, eds. Myology. New York: McGraw-Hill, 1994: 1661-78.
2. Iaizzo PA, Palahniuk RJ. Malignant hyperthermia: diagnosis, treatment, genetics and pathophysiology. Invest Radiol 1991;26: 1013-8.
3. Louis CF, Zualkernan K, Roghair T, Mickelson JR. The effects of volatile anesthetics on calcium regulation by malignant hyperthermia-susceptible sarcoplasmic reticulum. Anesthesiology 1992;77:114-25.
4. 2+ in the ryanodine receptor of human malignant hyperthermia. Am J Physiol 1991;30:C237-45.
5. Gillard EF, Otsu K, Fujii J, et al. A substitution of cysteine for arginine 614 in thr ryanodine receptor is potentially causative of human malignant hyperthermia. Genomics 1991;11:751-5.
6. Seewald M, Eichinger HM, Iaizzo PA. An altered phospholipid and fatty acid composition of muscle membranes obtained from pigs susceptible to malignant hyperthermia. Acta Anaesthesiol Scand 1991;35:380-6.
7. Iaizzo PA, Klein W, Lehmann-Horn F. Fura-2 detected myoplasmic calcium and its correlation with contracture force in skeletal muscle from normal and malignant hyperthermia susceptible pigs. Pflugers Arch 1988;411:648-53.
8. Quinlan JG, Iaizzo PA, Gronert GA, Taylor SR. Use of dantrolene plus multiple pulses to detect stress-susceptible porcine muscle. J Appl Physiol 1986;60:1313-20.
9. 2/δ-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families. Hum Mol Genet 1994;3:969-75.
10. Quane KA, Keating KE, Manning BM, et al. Detection of a novel common mutation in the ryanodine receptor gene in malignant hyperthermia: implications for diagnosis and heterogeneity studies. Hum Mol Genet 1994;3:471-6.
11. Sudbrak R, Procaccio V, Klausnitzer M, et al. Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1. Am J Hum Genet 1995;56:684-91.
12. Berman MC, Harrison GC, Bull AB, Kench JE. Changes underlying halothane-induced malignant hyperpyrexia in Landrace pigs. Nature 1970;225:653-5.
13. Foster PS, Hopkinson KC, Denborough MAS. Propofol anaesthesia in malignant hyperpyrexia susceptible swine. Clin Exp Pharmacol Physiol 1992;19:183-6.
14. Wedel DJ, Iaizzo PA, Milde JH. Desflurane is a trigger of malignant hyperthermia in susceptible swine. Anesthesiology 1991;74:508-12.
15. Wedel DJ, Gammel SA, Milde JH, Iaizzo PA. Delayed onset of malignant hyperthermia induced by isoflurane and desflurane compared to halothane in susceptible swine. Anesthesiology 1993;78:1138-44.
16. Hall GM, Bendall JR, Lucke JN, Lister D. Porcine malignant hyperthermia. II. Heat production. Br J Anaesth 1976;48:305-8.
17. Berman MC, Harrison GG, Bull AB, Kenc JE. Changes underlying halothane-induced malignant hyperthermia in Landrace pigs. Nature 1970;255:653-5.
18. Heier T, Caldwell JE, Sessler DI, Miller RD. Mild intraoperative hypothermia increases duration of action and spontaneous recovery of vecuronium blockade during nitrous oxide-isoflurane anesthesia in humans. Anesthesiology 1991;74:815-9.
19. Sessler DI, Rubinstein EH, Moayeri A. Physiological responses to mild perianesthetic hypothermia in humans. Anesthesiology 1991;75:594-610.
20. 2 monitoring. Its use in the diagnosis and management of malignant hyperthermia. Anaesthesia 1984;39:1000-3.
21. Bissonnette B, Sessler DI, LaFlamme P. Intraoperative temperature monitoring sites in infants and children and the effect of inspired gas warming on esophageal temperature. Anesth Analg 1989;69:192-6.
22. Brull SJ, O'Conner TZ, Poglitsch E, et al. Comparison of crystalline skin temperature to esophageal temperatures during anesthesia [abstract]. Anesthesiology 1990;73:A472.
23. Cork RC, Vaughan RW, Humphrey LS. Precision and accuracy of intraoperative temperature monitoring. Anesth Analg 1983; 62:211-4.
24. Jones DE, Ryan JF. Treatment of acute hyperthermia crises. In: Britt BA, ed. Malignant hyperthermia. Boston: Martinus Nijhoff Publishing, 1987:393-406.
25. Sessler DI, Moayeri A. Skin-surface warming: heat flux and central temperature. Anesthesiology 1990;73:218-24.
26. Ward A, Chaffman MO, Sorkin EM. Dantrolene. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in malignant hyperthermia, the neuroleptic malignant syndrome and an update of its use in muscle spasticity. Drugs 1986;32:130-68.
27. Gronert GA, Theye RA, Milde JH, Tinker JH. Catecholamine stimulation of myocardial oxygen consumption in porcine malignant hyperthermia. Anesthesiology 1978;49:330-7.
28. Lucke JN, Hall GM, Lister D. Porcine malignant hyperthermia. I. Metabolic and physiological changes. Br J Anaesth 1976;48: 297-304.
29. 2+,] in human skeletal muscle. Cell Calcium 1989;10:151-8.
30. Seewald M, Eichinger HM, Iaizzo PA. An altered phospholipid and fatty acid composition of muscle membranes obtained from pigs susceptible to malignant hyperthermia. Acta Anaesthesiol Scand 1991;35:380-6.
31. Ryan JF, Lopez JR, Sanchez VB, et al. Myoplasmic calcium changes precede metabolic and clinical signs of porcine malignant hyperthermia. Anesth Analg 1994;79:1007-11.
32. 2+ induced by halothane in hepatocytes isolated from swine susceptible to malignant hyperthermia. Anesthesiology 1991;74:531-8.
33. Duthie GG, McPhail DB, Arthur JR, et al. Spin trapping of free radicals and lipid peroxidation in microsomal preparations from malignant hyperthermia susceptible pigs. Free Radic Res Commun 1990;8:93-9.
34. Gallant EM, Fletcher TF, Goettl VM, Rempel WE. Porcine malignant hyperthermia: cell injury enhances halothane sensitivity of muscle biopsies. Muscle Nerve 1986;9:174-84.
35. Ørding H, Hald A, Sjontoft E. Malignant hyperthermia triggered by heating in anaesthetized pigs. Acta Anaesthesiol Scand 1985;29:698-701.